Mayes et al v. The United States of America

Filing 63

ORDER Granting 61 Stipulation re FRCP Rule 35 Examination. Signed by Magistrate Judge Brenda Weksler on 2/6/2024. (Copies have been distributed pursuant to the NEF - JQC)

1 JASON M. FRIERSON
United States Attorney
2 District of Nevada
Nevada Bar No. 7709
3
SUMMER A. JOHNSON
4 Assistant United States Attorney
501 Las Vegas Blvd. South, Suite 1100
5 Las Vegas, Nevada 89101
Telephone: [phone]
6 Email: [e-mail]
7 Attorneys for Defendant United States of America
8

UNITED STATES DISTRICT COURT

9

DISTRICT OF NEVADA

10 Lucille Lagasse, as Guardian for Harry
Michael Reid; and, Lucille Lagasse,
11
12
13

Plaintiff,
v.

The United States of America; DOE
14 Individuals I-X; and ROE Entities I-X,
inclusive,
15
Defendants.
16

Case No. 2:21-cv-00296-APG-BNW
STIPULATION AND ORDER RE
FRCP RULE 35 EXAMINATION
OF PLAINTIFF HARRY
MICHAEL REID
(CORRECTED)

17
18

IT IS HEREBY STIPULATED by and between Plaintiff LUCILLE LAGASSE, as

19 Guardian for Harry Michael Reid, and Defendant UNITED STATES OF AMERICA
20 through their respective attorneys of record as follows:
21

1.

Plaintiff, Harry Michael Reid will undergo a neuropsychological examination

22 conducted by Ari Kalechstein, Ph.D. A copy of Dr. Kalechstein’s curriculum vitae is
23 attached as Exhibit A.
24

2.

The examination will occur on February 9, 2024 at 8:30 a.m. at 501 Las

25 Vegas Blvd, South, Suite 1100, Las Vegas, Nevada 89101. The examination will take a
26 maximum of 8 hours to complete. The examination will end immediately on or before the 8
27 hour mark. The 8 hours will not include comfort or meal breaks taken during the
28 examination period.

1

3.

No other persons shall be present during the examination other than Plaintiff

2 Harry Michael Reid, Dr. Kalechstein, and members of his staff.
3

4.

Dr. Kalechstein shall not physically examine Plaintiff or provide opinions in

4 fields that are outside the area of his expertise.
5

5.

Dr. Kalechstein will not conduct any diagnostic tests or procedures that are

6 painful, protracted, intrusive, or unreasonably invasive, nor conduct any diagnostic
7 imaging.
8

6.

The examination will consist of one session, which will include: (1) a clinical

9 interview with Plaintiff Harry Michael Reid to discuss the following: his clinical situation
10 and obtain a bio-psycho-social history, including Plaintiff’s recent and past personal, family,
11 social, developmental, substance-abuse, medical, psychiatric, educational, occupational,
12 relationship, trauma and legal histories; and (2) standard cognitive testing, which may
13 include the following: b–test; Auditory Consonant Trigrams; Boston Diagnostic Aphasia
14 Exam and/or Western Aphasia Battery; Brief Visuospatial Memory Test – Revised;
15 California Verbal Learning Test – 2 or 3; Continuous Performance Test – 2 or 3; Controlled
16 Oral Word Association Test; Delis-Kaplan Executive Functioning System; Dot Counting
17 Test; Finger Tapping Test; Grooved Pegboard Test; Judgment of Line Orientation;
18 Minnesota Multiphasic Personality Inventory-2 or 2-RF or 3; Personality Assessment
19 Inventory; Rey Auditory Verbal Learning Test; Rey–Osterrieth Complex Figure Test; Ruff
20 Figural Fluency Test; Scholastic Abilities Test for Adults (SATA); Selective Reminding
21 Test; Stroop Test; Symbol Digit Modalities Test; TOMM;
22 Trailmaking Test-Parts A and B; Victoria Symptom Validity Test; Wechsler Adult
23 Intelligence Scale – III or IV; Wechsler Memory Scale – III or IV; Wisconsin Card Sorting
24 Test; Woodcock–Johnson Tests of Academic Achievement – IV.
25 Not all of the evaluation tools may be administered and will be determined by Dr.
26 Kalechstein at the time of the examination.
27 ///
28 ///
2

1

7.

No other testing besides those listed above will be conducted.

2

8.

Dr. Kalechstein and Plaintiff Harry Michael Reid will be the sole persons

3 participating in the examination. Dr. Kalechstein will digitally audio record the session in
4 its entirety. Plaintiff may voice-record the clinical interview and may leave with the
5 recording in his possession. Plaintiff may voice record the test-administration but must turn
6 over the recording to Dr. Kalechstein who will place the recording of the test-administration
7 in an envelope, seal it, and have Plaintiff sign it. Dr. Kalechstein will send the unopened
8 enveloped to Plaintiff’s identified expert.
9

9.

Medical billing, medical records, and diagnostic films have been produced

10 during litigation. To the extent Dr. Kalechstein needs to review these records, Defendant
11 will be responsible for providing them to Dr. Kalechstein prior to the examination. Plaintiff
12 shall not bring any medical records, medical bills or diagnostic imaging to the examination.
13

10.

Within four (4) weeks of the examination, or on the date of the expert

14 disclosure, whichever occurs earlier, the examiner shall provide to Defendant’s counsel a
15 written report of the examination, including results of all tests, diagnoses and conclusions.
16

11.

Defendant shall produce a report prepared by Dr. Kalechstein to Plaintiff’s

17 counsel within thirty (30) days of the examination, or in accordance with the applicable
18 Discovery Scheduling Order, whichever comes first.
19

12.

Dr. Kalechstein will produce a copy of his file upon request of Plaintiff’s

20 counsel, in accordance with the professional guidelines for psychologists.
21

13.

Dr. Kalechstein will not speak with or attempt to engage any family member

22 or friend who may accompany the Plaintiff to the examination. Plaintiff understands that no
23 family member and/or friend shall be present while any portion of the evaluation is being
24 conducted.
25

14.

Dr. Kalechstein will receive a copy of this executed Stipulation prior to the

26 examination.
27

15.

Plaintiff shall not pay or incur any fee associated with the examination.

28

16.

The cost of this examination shall be borne by the United States.
3

1

17.

The parties agree and stipulate that the exam is being conducted pursuant to

2 FRCP 35 and the parties and examiner agree to comply with the provisions of FRCP 35.
3

IT IS SO STIPULATED.

4

Dated this 6th day of February 2024

Dated this 6th day of February 2024

5

CLOSE LAW GROUP

JASON M. FRIERSON
United States Attorney

/s/ Jason Close
JASON A. CLOSE, ESQ.

/s/ Summer A. Johnson
SUMMER A. JOHNSON
Assistant United States Attorney

6
7
8
9
10
11
12
13
14
15
16
17
18
19

Attorneys for Plaintiffs

Attorneys for Defendant

Dated this 6th day of February 2024
THE LAW OFFICE OF EGLET
ADAMS EGLET HAM HENRIOD
/s/ Artemus W. Ham
ROBERT T. EGLET, ESQ.
ROBERT M. ADAMS, ESQ.
ARTEMUS W. HAM, ESQ.
CASSANDRA S.M. CUMMINGS, ESQ.
ASHLEY E. KABINS, ESQ.
ASHLEY B. GUGINO, ESQ.
Attorneys for Plaintiffs

ORDER
IT IS SO ORDERED:

20
21
22
23
24

HONORABLE BRENDA WEKSLER
UNITED STATES MAGISTRATE JUDGE
2/6/2024
DATED: ______________________________

25
26
27
28
4

Case 2:21-cv-00296-APG-BNW Document 61-1 Filed 02/06/24 Page 1 of 1

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28

Index of Exhibits
Exhibit A …………… Ari Kalechstein, Ph.D., Curriculum Vitae

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 1 of 25

Exhibit A
Ari Kalechstein, Ph.D.
Curriculum Vitae

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 2 of 25

CURRICULUM VITAE: Ari Kalechstein, Ph.D.
PROFESSIONAL EMPLOYMENT:
7/1999 – 7/2003

UCLA School of Medicine, Assistant Research Psychologist,
Department of Psychiatry and Biobehavioral Sciences

8/2003 – 6/2009

David Geffen School of Medicine at UCLA, Associate Research
Psychologist, Department of Psychiatry and Biobehavioral Sciences

6/2009 – present

Baylor College of Medicine, Adjunct Associate Professor, The
Menninger Department of Psychiatry and Behavioral Sciences

8/1996 – present

Private practice, President, Ari Kalechstein,
Associates/Executive Mental Health, Inc.

Ph.D.,

and

EDUCATION:
1996 – 1999

UCLA Neuropsychiatric Institute, Postdoctoral Fellow in Substance
Abuse

1995 – 1997

UCLA Neuropsychiatric
Neuropsychology

1994 – 1995

VA Medical Center West Los Angeles, Intern in Clinical Psychology

1992 – 1995

Emory University, Ph.D. in Clinical Psychology

1989 – 1991

Emory University, M.A. in Clinical Psychology

1983 – 1988

California State University, Northridge, B.A., Psychology

Institute,

PRE-DOCTORAL PROFESSIONAL TRAINING:
VA Medical Center, West Los Angeles, CA
Patton State Hospital, Redlands, CA
Emory University Neurobehavioral Program, Atlanta, GA
Wesley Woods Geriatric Hospital, Atlanta, GA
Grady Hospital, Atlanta, GA
Emory University Psychology Center, Atlanta, GA

Postdoctoral

Fellow

in

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 3 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 2

CERTIFICATION
Certificate of Professional Qualification in Psychology from Association of State and
Provincial Psychology Boards
Los Angeles Superior Court Expert Witness Panel (2011 – 2014)
ACADEMIC AWARDS AND HONORS:
Co-chief Postdoctoral Fellow in Neuropsychology (9/96 – 9/97).
National Institute of Drug Abuse Director’s Travel Award for 50th Conference for College
on Problems of Drug Dependence (6/00).
National Institute of Mental Health funded Postdoctoral Fellow in Substance Abuse
(9/96 – 6/99).
Emory University full tuition scholarship and research fellowship (8/89 – 5/94).
Graduated cum laude C.S.U., Northridge (5/88).
Dean's List
Los Angeles Business Journal – 2022 – Finalist
-

Innovator of the Year

-

Telehealth program of the year

PROFESSIONAL LICENSURE:
Licensed Psychologist (Clinical) in the following states:
Alaska (License – 150137); awarded on 07/27/2020
California (License – PSY14872): awarded in 8/1996
Nevada (License – PY0444): awarded in 8/2002
Virginia (License – 0810006372); awarded on 12/05/2019
PROFESSIONAL MEMBERSHIPS:
International Neuropsychological Society
National Academy of Neuropsychology
BOARD MEMBERSHIPS
Expert Reviewer, Board of Psychology, State of California
Examiner, Medical Board, State of California

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 4 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 3

COMMITTEE MEMBERSHIPS:
Consulting editor for the following journal:
Journal of Clinical and Experimental Neuropsychology
Guest editor:
Frontiers in Psychology
Ad hoc reviewer for the following journals:
Addiction
Addictive Behaviors
AIDS and Behavior
American Journal of the Addictions
American Journal of Drug and Alcohol Abuse
Applied Neuropsychology
Archives of General Psychiatry
Clinical Medicine Insights
Clinical Neuropsychologist
CNS Spectrum
Current Alzheimer’s Research
Drug and Alcohol Dependence
Frontiers in Behavioral Neuroscience
Frontiers in Psychiatry
Human Psychopharmacology: Clinical and Experimental
International Journal of Neuropsychopharmacology
Journal of Addiction Research and Therapy
Journal of Clinical and Experimental Neuropsychology
Journal of Neuropsychiatry and Clinical Neurosciences
Journal of Gambling Studies
Neuropsychology
Neuropsychopharmacology
Pediatrics

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 5 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 4

COMMITTEE MEMBERSHIPS (cont.):
Ad hoc reviewer for the following journals (cont.):
Progress in Neuropsychopharmacology and Biological Psychiatry
Psychiatry Research
Psychological Assessment
Psychology of Addictive Behaviors
Psychopharmacology
Scientific World Journal
Substance Abuse Treatment, Prevention, and Policy
Ad hoc reviewer for the following facility:
Centinela Hospital staff privileges committee
Ad hoc reviewer for National Institute on Drug Abuse:
Special Emphasis Panel/Scientific Review Group 2007/05 ZDA1 MXS-M (26)
American Recovery and Reinvestment Act 2009/Stage I reviewer/Biobehavioral
Regulation, Learning, and Ethology Study Section
Bioethics committee, Hollywood Presbyterian Medical Center, 2011 – 2014
HOSPITAL STAFF MEMBERSHIPS:
UCLA Medical Center (privileges received on case-by-case basis)
GRANT SUPPORT:
1.

Kalechstein, Ari D. (Principal Investigator). Neuropsychological Sequelae of Longterm Methamphetamine Use. Awarded by VAMC West Los Angeles Medication
Development Research Unit.

2.

Kalechstein, Ari D. (Co-Investigator). The HPA Axis and Cue Reactivity in
Methamphetamine Dependent Individuals. Awarded by UCLA Neuropsychiatric
Institute. (Dates: 1999-2000).

3.

Kalechstein, Ari D. (Principal Investigator). Methamphetamine as a Risk Factor for
Neuropsychological Impairment in HIV-Seropositive Asymptomatic Individuals.
Awarded by Universitywide AIDS Research Program (1999-2000).

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 6 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 5

GRANT SUPPORT (cont.):
4.

Kalechstein, Ari D. (Co-Investigator). Clinical Trials: Operations Unit. Awarded by
the National Institute on Drug Abuse (2000-2005): Total Award: ~$20,000,000.

5.

Kalechstein, Ari D. (Co-Investigator): Clinical Research Education for Drug Abuse
Professionals. Awarded by the National Institute on Drug Abuse (2002-2007).

6.

Kalechstein, Ari D. (Co-Investigator): Annenberg Foundation Grant: UCLA
Gambling Studies Program.

7.

Kalechstein, Ari D. (Principal Investigator). Methamphetamine Dependence:
Treating Neurocognitive Impairment. Awarded by National Institute on Drug
Abuse (2005 – 2006).

8.

Kalechstein, Ari D. (Principal Investigator). Methamphetamine Dependence:
Treating Neurocognitive Impairment. Awarded by National Institute on Drug
Abuse via P20 mechanism (2007 – 2008).

9.

Kalechstein, Ari D. (Co—investigator). Rivastigmine as a Potential Treatment for
Methamphetamine Addiction. Awarded by National Institute on Drug Abuse (2008
– 2011).

10. Kalechstein, Ari D. (Co—investigator). Cycloserine Enhancement of Extinction
Learning. Awarded by National Institute on Drug Abuse (2008 – 2009).
11.

Kalechstein, Ari D. (Co—investigator). Rivastigmine and Huperzine A as Potential
Treatments for Cocaine Addiction. Awarded by National Institute on Drug Abuse
(2009 – 2013).

12. Kalechstein, Ari D. (Co—investigator). Exercise as a Behavioral Treatment for
Cocaine Dependence. Awarded by National Institute on Drug Abuse (2011 – 2012).
13. Kalechstein, Ari D. (Co—investigator).
Varenicline as a Treatment for
Methamphetamine Dependence. Awarded by National Institute on Drug Abuse
(2009 – 2013).
14. Kalechstein, Ari D. (Co—investigator).
Stimulant Pharmacotherapy:
Noradrenergic Targets. Awarded by National Institute on Drug Abuse (2009 –
2014).
15.

Kalechstein, Ari D. (Co—investigator). Modafinil and Escitalopram for Cocaine
Dependence. Awarded by National Institute on Drug Abuse (2009 – 2014).

16. Kalechstein, Ari D. (Consultant). Trauma Recovery Center.
California Crime Victim Compensation Board (2021 – 2023).

Awarded by the

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 7 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 6

RESEARCH PUBLICATIONS:
1.

Cochran, S., Keidan, J., Kalechstein, A. (1990). Sexually transmitted diseases and
acquired immunodeficiency syndrome (AIDS): Changes in risk reduction behaviors
among young adults. Sexually Transmitted Diseases, 17, 80-86.

2.

Kalechstein, A., & Nowicki, S., Jr. (1994). Social learning theory and the prediction
of individual differences in achievement in telemarketers. Journal of Social
Psychology, 134, 547-548.

3.

Goldstein, F., Levin, H., Roberts, V., Goldman, W., Kalechstein, A., Winslow, M., &
Goldstein, S. (1996). Neuropsychological effects of closed head injury in older
adults: A comparison with Alzheimer’s Disease. Neuropsychology, 10, 147-154.

4.

Kalechstein, A., & Nowicki, S., Jr. (1997). A meta-analytic examination of the
relationship between control expectancies and academic achievement: An 11-year
follow-up to Findley and Cooper. Genetic, Social, and General Psychology
Monographs, 129, 29-59.

5.

Van Gorp, W. G., Kalechstein, A. D., Moore, L. H., Hinkin, C. H., Mahler, M. E., Foti,
D., & Mendez, M. (1997). A clinical comparison of two forms of the Card Sorting
Test. The Clinical Neuropsychologist, 11, 155-160.

6.

Rapport, L., Axelrod, B., Thiesen, M., Brines, D., Kalechstein, A., & Ricker, J. (1997).
The relationship of IQ to verbal learning and memory: Test and retest. Journal of
Clinical and Experimental Neuropsychology, 17, 655-666.

7.

Kalechstein, A., van Gorp, W. G., & Rapport, L. (1998). Variability in clinical
classification of raw test scores across normative data sets. The Clinical
Neuropsychologist, 12, 339-347.

8.

Kalechstein, A., Hinkin, C., van Gorp, W., Castellon, S., & Satz, P. (1998). Depression
affects procedural but not episodic memory. Journal of Clinical and Experimental
Neuropsychology, 20, 529-535.

9.

Kalechstein, A., & van Gorp, W. G. (1998). Outcomes Assessment for Forensic
Neuropsychology:
Recommendations
and
Considerations.
Applied
Neuropsychology, 5, 202-208.

10.

Goldstein, F., Levin, H., Goldman, W., Kalechstein, A., Clark, A. (1999). Cognitive
and behavioral sequelae of closed head injury in older adults according to their
significant others. Journal of Neuropsychiatry and Clinical Neurosciences, 11, 3844.

11.

Uslaner, J., Kalechstein, A, Richter, T, Ling, W, & Newton, T. (1999). Association of
depressive symptoms during abstinence with the subjective high produced by
cocaine. American Journal of Psychiatry, 156, 1444-1446.

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 8 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 7

RESEARCH PUBLICATIONS (cont.):
12.

Newton, T., A., Kalechstein, A., Beckson, M., Bartzokis, G., Lindholm, J., Bridge, P.,
& Ling, W. (1999). Effects of selegeline pretreatment on response to experimental
cocaine administration. Psychiatry Research, 87, 101-106.

13.

Van Gorp, W. G., Humphrey, L. A., Kalechstein, A. D., McMullen, W., Brumm, V., &
Stoddard, M. (1999). Identifying malingerers of neurocognitive impairment using
traditional neuropsychological instruments. Journal of Clinical and Experimental
Neuropsychology, 21, 245-250.

14.

Kalechstein, A., Newton, T. F., Longshore, D., van Gorp, W. G., Anglin, M.D., &
Gawin, F. H. (2000). Psychiatric comorbidity in methamphetamine abusers.
Journal of Neuropsychiatry and Clinical Neurosciences, 12, 480-484.

15.

Newton, T., A., Kalechstein, A., Uslaner, J. M., Tervo, K. E., & Ling, W. (2001).
Risperidone reduces the euphorigenic effects of experimentally administered
cocaine. Psychiatry Research, 102, 227-233.

16.

Kalechstein, A.D., Newton, T. F., & Leavengood, A.H. (2002). Apathy syndrome in
cocaine dependence. Psychiatry Research, 109, 97 – 100.

17.

Newton, T. F., Cook, I. A., Kalechstein, A. D., Duran, S. D., Monroy, F., Ling, W. &
Leuchter, A. F. (2003). Quantitative EEG Abnormalities in Recently Abstinent
Methamphetamine Dependent Individuals. Clinical Neurophysiology, 114, 410 –
415.

18.

Newton, T. F., Kalechstein, A. D., & Tervo, K. E., & Ling, W. (2003). Irritability
following abstinence from cocaine predicts euphoric effects of cocaine
administration. Addictive Behaviors, 28, 817 – 821.

19.

Kalechstein, A.D., Newton, T. F., & Green, M. F. (2003). Methamphetamine
dependence is associated with neurocognitive impairment in the initial phases of
abstinence. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 210 – 215.

20.

Kalechstein, A. D., Newton, T. F., & van Gorp, W. G. (2003). A meta-analytic review
of the association between neuropsychological profile and vocational outcomes.
Journal of Clinical and Experimental Neuropsychology, 25, 1186 – 1191.

21.

Newton, T. F., Kalechstein, A.D., Hardy, D. J., Cook, I. A., Nestor, L., Ling, W. &
Leuchter, A. F. (2004). Quantitative EEG Abnormalities are Associated with
Memory Impairment in Methamphetamine Dependence: Preliminary Findings
Clinical Neurophysiology, 115, 194 – 198.

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 9 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 8

RESEARCH PUBLICATIONS (cont.):
22.

Newton, T. F., Kalechstein, A. D., Duran, S. D., van Sluis, N., & Ling, W. (2004).
Methamphetamine Abstinence Syndrome: Preliminary Findings.
American
Journal of Addiction, 13, 248 – 255.

23.

Kalechstein, A. D., and van Gorp, W. G. (2005). Threats to the interpretation and
conveyance of forensic neuropsychological results.
Journal of Forensic
Neuropsychology, 67 – 77.

24.

De La Garza, R., Newton, T. F., Kalechstein, A. D., & Ling, W. (2005). Risperidone
diminishes cocaine-induced craving. Psychopharmacology, 78, 347 – 350.

25.

Newton, T. F., Kalechstein, A D., De La Garza, R., II, & Cutting, D., & Ling, W.
(2005).
Apathy predicts hedonic but not craving response to cocaine.
Pharmacology, Biochemistry, and Behavior, 82, 236 – 240.

26.

Newton, T. F., De La Garza, R., II, Kalechstein, A. D., & Nestor, L., (2005). Cocaine
and Methamphetamine Produce Different Patterns of Subjective and Cardiovascular
Effects. Pharmacology, Biochemistry, and Behavior, 82, 90 - 97.

27.

Kalechstein, A. D., Newton, T.F., De La Garza, R., II & Mahoney, J. (2007). The
neurocognitive consequences of recreational MDMA use: A meta-analytic review.
Psychopharmacology, 189, 531 – 537.

28.

Kalechstein, A. D., Fong, T. W., Newton, T.F., De La Garza, R., II & Rosenthal, R.
(2007). Pathological Gamblers Demonstrate Frontal Lobe Impairment: Preliminary
Findings. Journal of Neuropsychiatry and Clinical Neurosciences, 19, 298 – 303.

29.

Mahoney, J. J., III, Kalechstein, A. D., De La Garza, R., II, & Newton, T. F. (2007).
Priming occurs following experimental cocaine administration: A meta-analytic
review. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 31, 593
– 599.

30.

Fong, T. F., Kalechstein, A.D., Bernhard, B., Rosenthal, R., & Rugle, L. (2008). A
double-blind, placebo-controlled trial of olanzapine for the treatment of video poker
pathological gamblers. Pharmacology, Biochemistry, and Behavior, 89, 298 – 303.

31.

Mahoney, III, J.J., Kalechstein, A.D., De La Garza, II, R., Newton, T.F. (2008).
Presence and persistence of psychotic symptoms in methamphetamine- versus
cocaine-dependent participants. American Journal of the Addictions, 17, 83 – 98.

32.

Kalechstein, A. D., Jentsch, J. D., & Kantak, K. (2008). Stimulant–Associated
Cognitive Abnormalities: Mechanisms and Impact on Reward-Related Behavior and
Addiction. Drug and Alcohol Dependence, 97, 276 – 280.

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 10 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 9

RESEARCH PUBLICATIONS (cont.):
33.

Newton, T. F., De La Garza, R., II, Kalechstein, A. D., Tsiortzis, D. & Jacobsen, C. A.
(2009). Theories of Addiction: Methamphetamine Users’ Explanations for
Continuing Drug Use and Relapse. American Journal of the Addictions, 18, 294—
300.

34.

Kalechstein, A.D., Newton, T. F., Green, M. F., Cook, I. A., & Leuchter, A. F. (2009).
Quantitative EEG Abnormalities are Associated with Memory Impairment in
Methamphetamine Dependence.
Journal of Neuropsychiatry and Clinical
Neurosciences, 21, 254 – 258.

35.

De La Garza, R., II , Ashbrook, L.H., Evans, S. E., Jacobsen, C.A., Kalechstein, A. D.,
& Newton, T. F. (2009). Influence of stress imagery on anxiety and desire for cocaine
in non—treatment seeking cocaine—addicted volunteers. American Journal of the
Addictions, 18, 481 – 487.

36.

Dean, A. C., London, E. D., Sugar, C. A., Kitchen, C. M., Swanson, A. N., Heinzerling,
K. G., Kalechstein, A. D., & Shoptaw, S. S. (2009). Predicting adherence to treatment
for methamphetamine dependence for neuropsychological and drug use variables.
Drug and Alcohol Dependence, 105, 48 – 55.

37.

Harwood, D.G., Kalechstein, A.D., Barker, W.W., St. George-Hyslop, P., & Duara, R.
(2009). Substance use and age of onset for Alzheimer’s disease. International
Journal of Geriatric Psychiatry, 25, 511—518.

38.

Kalechstein, A.D., De La Garza, R., II, & Newton, T. F., (2010). Modafinil
administration improves working memory in methamphetamine-dependent
individuals who demonstrate baseline impairment. American Journal of the
Addictions, 19, 340—344.

39.

Mahoney, J. J., III, Hawkins, R. Y., De La Garza, R., II, Kalechstein, A. D., & Newton,
T. F. (2010). The relationship between gender and psychotic symptoms in cocainedependent and methamphetamine-dependent participants. Gender Medicine, 27,
414—421.

40. Mahoney, J . J, III, Jackson, B. J., Kalechstein, A. D., De La Garza, R., & Newton, T.

F.
(2011). Acute, low-dose methamphetamine administration improves
attention/information
processing
speed
and
working
memory
in
methamphetamine-dependent
individuals.
Progress
in
NeuroPsychopharmacology & Biological Psychiatry, 35, 459—465.

41.

Tziotoris, D., Mahoney, J . J, III, Kalechstein, A. D., Newton, T. F., & De La Garza,
R. (2011). The relationship between impulsivity and craving in cocaine- and
methamphetamine dependent volunteers. Pharmacology Biochemistry and
Behavior, 98, 196 – 202.

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 11 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 10

RESEARCH PUBLICATIONS (cont.):
42.

Kalechstein, A.D., Yoon, J. H., Croft, D.E., Jaeggi, S., & De La Garza, R., II. (2011).
Low—dose, short—term rivastigmine administration does not affect neurocognition
in methamphetamine dependent individuals. Pharmacology Biochemistry and
Behavior, 99, 423 – 427.

43.

Mahoney, J . J, III, Jackson, B. J., Kalechstein, A.D., De La Garza, R., II, Chang, L.,
& Newton, T. F. (2012). Acute modafinil exposure reduces daytime sleepiness in
abstinent methamphetamine—dependent volunteers. International Journal of
Neuropsychopharmacology, 4, 1 – 9.

44.

Kalechstein, A.D., Yoon, J. H., Croft, D.E., Newton, T. F., & De La Garza, R., II.
(2012). Effects of D-cycloserine on neurocognition in cocaine and nicotine
dependent individuals. Pharmacology Biochemistry and Behavior, 103, 403 – 407.

45.

Kalechstein, A.D., Yoon, J. H., Mahoney, J. J., & De La Garza, R., II. (2013).
Modafinil, but not modafinil and sertraline, administration is associated with
improved working memory in long—term, high—dose cocaine users.
Neuropharmacology, 64, 974 – 979.

46.

Mahoney, J . J, III, Kalechstein, A.D., Verrico, C. D., Arnoudse, B. A., Shapiro, B., &
De La Garza, R., II. (2014). Preliminary findings of the effects of rivastigmine, an
acetylcholinesterase inhibitor, on working memory cocaine-dependent volunteers.
Progress in Neuropsychopharmacology and Biological Psychiatry, 50, 137 – 142.

47.

Kalechstein, A.D., Mahoney, J. J., III, Verrico, C. D., & De La Garza, R., II. (2014).
Short-term, low-dose varenicline administration enhances information processing
speed in methamphetamine-dependent users. Neuropharmacology, 85, 493-498.

48.

Mahoney, J. J, III, Kalechstein, A.D., DMarco, A. P.,Newton, T. F., & De La Garza,
R., II. (2017). The relationship between premorbid IQ and neurocognitive
functioning in individuals with cocaine use disorders. Neuropsychology, 31, 311318.

49.

Mahoney, J . J, III, Kalechstein, A.D., Newton, T. F., & De La Garza, R., II. (2017).
Cocaine use patterns do not impact neurocognitive functioning in individuals with
cocaine use disorder. Journal of Psychopharmacology, 31, 989-995.

50.

Nowicki, S. Iles-Craven, Y., Kalechstein, A., & Golding, J. (2021). Editorial: Locus
of Control: Antecedents, Consequences, and Interventions Using Rotter’s
Definition. Frontiers of Psychology, 12, 1-3.

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 12 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 11

PUBLICATIONS – NOT PEER REVIEW:
1.

Kalechstein, A. D. (2020). How a mental health practice switched to telehealth.
Healthcare Global (online); https://www.healthcareglobal.com/telehealth-andcovid-19/how-mental-healthcare-practice-switched-telehealth.

2.

Kalechstein, A. D. (2020). Leading through a crisis: 5 factors for success. Sales and
Marketing
Management
(print
and
online);
https://salesandmarketing.com/content/leading-through-crisis-5-factors-success.

3.

Kalechstein, A. D. (2020). Shut Out of Nursing Facilities, a Post-Acute Mental
Health Practice Pivots to Virtual on the Fly. Skilled Nursing News (Newsletter and
Online); https://skillednursingnews.com/2020/09/shut-out-of-nursing-facilitiesa-post-acute-mental-health-practice-pivots-to-virtual-on-the-fly/

4.

Kalechstein, A. D. (2020). Technologies and strategies to maintain productivity
during
telehealth
transition.
Health
IT
News
(online);
https://www.healthcareitnews.com/news/technologies-and-strategies-maintainproductivity-during-telehealth-transition.

5.

Kalechstein, A. D. (2021). Executive Outlook 2021: Redefining the Relationship
Between Nursing Homes, Physicians. Skilled Nursing News (Newsletter and
Online);
https://skillednursingnews.com/2021/01/executive-outlook-2021redefining-the-relationship-between-nursing-homes-physicians/

6.

Kalechstein, A. D. (2021). How COVID-19 affects the brain and what to do about it.
McKnight’s
Long-Term
Care
News;
https://www.mcknights.com/marketplace/marketplace-experts/how-covid-19affects-the-brain-and-what-to-do-about-it/

7.

Kalechstein, A. D. (2021). Dr. Ari Kalechstein of Executive Mental Health: Five
things you need to be a highly effective leader during turbulent times;
https://medium.com/authority-magazine/dr-ari-kalechstein-of-executive-mentalhealth-five-things-you-need-to-be-a-highly-effective-5407cce7458b

8.

Kalechstein, A. D. (2021). SNF Patients Face Increasingly Complex Problems – And
Operators Need to Plan Accordingly; Skilled Nursing News (Newsletter and
Online); https://skillednursingnews.com/2021/06/snf-patients-face-increasinglycomplex-problems-and-operators-need-to-plan-accordingly

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 13 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 12

BOOK REVIEWS
1.

Kalechstein, A. D. (2008). Unmasking deception.
Experimental Neuropsychology, 30, 734 – 737.

Journal of Clinical and

2.

Kalechstein, A. D. (2009). A neuroeconomics text stimulated my medial forebrain
bundle. Journal of Gambling Studies (in press).

3.

Kalechstein, A. D., & Van Gorp, W. G. (2009). Unmasking deception – redux.
Applied Neuropsychology, 16, 234 – 236.

4.

Kalechstein,A. D. (2010). Midbrain Mutiny: The Picoeconomics and
Neuroeconomics of Disordered Gambling. Journal of Gambling Studies, 23, 179—
18

CHAPTERS AND BOOKS:
1. Anglin, M. D., Kalechstein, A. D., Maglione, M. M., Annon, J., Fiorentine, R. (1997).
Methamphetamine abuse epidemiology and treatment in California: A regional
report.
2. Kalechstein, A. D., van Gorp, W. G., & Newton, T. F. (1999). Differential diagnosis in
individuals infected with HIV. In J. Ricker (Ed.). Differential Diagnosis in Adult
Neuropsychological Assessment.
New York, NY: Springer-Verlag Publishing
Company.
3. Kalechstein, A. D., van Gorp, W. G., & Zelen, G. (2004). Application of
neuropsychological assessment in a forensic setting. In J. Lowinson, P. Ruiz, R. B.
Millman, and J. G. Langrod (Eds.). Substance Abuse: A Comprehensive Textbook. (4th
ed.). New York, NY: Lippincott, Williams, & Wilkins.
4. Kalechstein, A. D., & van Gorp, W. G. (2007). Neuropsychology and Substance Use:
State of the Art and Future Directions. Boston, MA: Taylor and Francis Publishers.
5. Kalechstein, A. D., and Newton, T. F. (2007). Methamphetamine. In A. Kalechstein
and W. van Gorp (Eds.). Neuropsychology and Substance Use: State of the Art and
Future Directions. Boston, MA: Taylor and Francis Publishers.
6. Kalechstein, A. D., Fantegrossi, W. F., Cowan, R., and Mahoney, J. J.. (2007). MDMA.
In A. Kalechstein and W. van Gorp (Eds.). Neuropsychology and Substance Use: State
of the Art and Future Directions. Boston, MA: Taylor and Francis Publishers.
7. Harwood, D. G., Sultzer, D., & Kalechstein, A. D. (2007). Substance use and aging. In
A. Kalechstein and W. van Gorp (Eds.). Neuropsychology and Substance Use: State of
the Art and Future Directions. Boston, MA: Taylor and Francis Publishers.

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 14 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 13

CHAPTERS AND BOOKS (cont.):
8. Monterosso, J., Kalechstein, A. D., & Cordova, X. (2007). If Only the Hangover
Preceded Intoxication: An Integration of Behavioral Economic and
Neuropsychological Approaches to Impulsive Choice.
Neuropsychology and
Substance Use: State of the Art and Future Directions. Boston, MA: Taylor and
Francis Publishers.
9. Kalechstein, A. D., De La Garza, R., Newton, T. F. (2009). Treatment for Addiction.
In R. E. Rakel and E. T. Bope (Eds.). Conn’s Current Therapy 2010. Toronto, Ontario,
Canada: Saunders Book Company.
10. Van Gorp, W. G., Kalechstein, A. D., & Scheiner, D. (2011). Neuropsychological effects
of substance abuse in adolescents. In D. De Crisce and P. Billick (Eds.). Clinical
Handbook of Adolescent Addictions. Toronto, Ontario, Canada: John Wiley & Sons,
Ltd.
11. De La Garza, R., & Kalechstein, A. D. (2011). Pharmacotherapeutic approaches to
cocaine and methamphetamine dependence. In C. Haile, T. F. Newton, R. De La
Garza, II, and T. Kosten (eds.). Advances in Treatment for Stimulant Dependence.
Arlington, Virginia: American Psychiatric Publishing.
PRESENTATIONS AND PROFESSIONAL MEETINGS:
1.

Kalechstein, A., Triplett, J., Rolfe, E., Rotstein, K., & Cochran, S. (1988). Little white
lies: Sexual dishonesty among college students. Presented at the 37th Annual
Meeting of the Western psychological Association, San Francisco, CA.

2.

Cochran, S., Keidan, J., Kalechstein, A. (1989). Sexually transmitted diseases:
Changes in risk behavior among young adults. Presented at the 98th Annual
Meeting of the American Psychological Association, New Orleans, LA.

3.

Baum, K., Kalechstein, A. (1993). Date rape prevalence and response. Presented at
the Fourth Annual meeting of the American Psychological Society, Chicago, IL.

4.

Kalechstein, A., Nowicki, S., Jr. (1993). Social learning theory and the prediction of
individual differences in achievement. Presented at the Fourth Annual Meeting of
the American Psychological Society, Chicago, IL.

5.

Goldstein, F., Levin, H., & Kalechstein, A. (1993). Cognitive and behavioral sequelae
of closed head injuries in older adults according to their significant others.
Presented at the International Neuropsychological Society 16th European
Conference.

6.

Goldstein, F., Levin, H., Roberts, V., & Kalechstein, A. (1995). Neuropsychological
features of older adults with closed head injury or Alzheimer's Disease. Presented at
the 23rd Annual Meeting of the International Neuropsychological Society.

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 15 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 14

PRESENTATIONS AND PROFESSIONAL MEETINGS (cont.):
7.

Kaufer, D. I., Hinkin, C. H., Kalechstein, A., Smushkovich, E., & Cummings, J.
(1995). Frontal-subcortical syndrome with Arnold-Chiari malformation: response to
fluoxetine. Presented at the seventh annual American Neuropsychiatric Association,
Pittsburgh, PA.

8.

Kalechstein, A. (1996). Invited Address: Theoretical and practical Applications of
neuropsychological assessment. Workshop presented to the Graduate Division of
the UCLA School of Nursing.

9.

Kalechstein, A. (1996). Invited Address: Fundamentals of neuropsychology: Who is
appropriate for neuropsychological assessment. Workshop presented to the Case
Management Division of the AIDS Project Los Angeles.

10. Kalechstein, A. (1996). Invited Address: Neuropsychological manifestations of
HIV-infection. Workshop presented to the Treatment Education Division of the
AIDS Project Los Angeles.
11.

Kalechstein, A. (1996). Invited Address: Neuropsychiatric manifestations of HIV-1
infection and opportunistic infections. Workshop presented to the Treatment
Education Division of the AIDS Project Los Angeles.

12. Kalechstein, A., Hinkin, C., van Gorp, W., Castellon, S., & Satz, P. (1996). The effects
of depression on episodic and procedural memory in HIV-infected persons.
Presented at the 24th Annual Meeting of the International Neuropsychological
Society.
13. Hinkin, C. H., Castellon, S. A., Wood, S., & Kalechstein, A. D. (1997). Cognitive
slowing in HIV-1 Infection. Presented at the 25th Annual Meeting of the
International Neuropsychological Society.
14. Kalechstein, A. D., Hinkin, C. H., Stenquist, P., van Gorp, W. G., Satz, P. et al. (1997).
Disease severity versus demographic characteristics as predictors of
neuropsychological dysfunction in HIV-infected patients. Presented at the 25th
Annual Meeting of the International Neuropsychological Society.
15.

Kalechstein, A. D., Longshore, D., Anglin, M. D., Hinkin, C. H., Simon, S., Ling, W.
(1997). Psychiatric comorbidity of methamphetamine dependence. Presented at the
49th Annual Meeting of the College on Problems of Drug Dependence.

16. Hinkin, C. H., Kalechstein, A. D., van Sluis, N., Kucukasci, S., Castellon, S., Simon,
S., & Ling, W. (1997). Methamphetamine abuse and reaction time deficits: a
preliminary report. Presented at the 17th Annual Meeting of the National Academy
of Neuropsychology.
17.

Evans, T., Kalechstein, A. D., Hinkin, C. H., van Sluis, N., Kucukasci, S., Castellon,
S., Simon, S., & Ling, W. (1997). The relationship between neurocognition and
capacity to perform activities of daily living: A preliminary report. Presented at the
17th Annual Meeting of the National Academy of Neuropsychology.

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 16 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 15

PRESENTATIONS AND PROFESSIONAL MEETINGS (cont.):
18. Kalechstein, A. D., Hinkin, C. H., van Sluis, N., Kucukasci, S., Castellon, S., Simon,
S., & Ling, W. (1998). The neurocognitive sequelae of methamphetamine
dependence in current users: A preliminary report. Presented at the 26 th Annual
Meeting of the International Neuropsychological Society.
19. Kalechstein, A. D., Newton, T. F., Shoptaw, S., Ling, W. (1998).
The
neuropsychological sequelae of methamphetamine dependence in recently
abstinent individuals: A preliminary report. Presented at the 50th Annual Meeting
of the College on Problems of Drug Dependence.
20. Kalechstein, A. (1999). Invited Address: Neuropsychiatric manifestations of HIV-1
infection and opportunistic infections. Workshop presented to UCLA CARE Clinic.
21. Kalechstein, A. (2000).
Invited Address: Apathy as an underdiagnosed
manifestation of HIV-1 infection. Workshop presented to the Los Angeles County
Department of Mental Health Task Force on HIV.
22. Kalechstein, A. (2000).
Invited Address: Neuropsychiatric manifestations of
methamphetamine dependence. Workshop presented at Grand Rounds of the
Daniel Freeman Memorial Marina Hospital.
23. Kalechstein, A. (2000). Invited Address: Neuropsychiatric manifestations of
methamphetamine dependence. Workshop presented at Grand Rounds of the
Daniel Freeman Memorial Marina Hospital, Los Angeles, California.
24. Kalechstein, A. (2000). Invited Address: Use of the Millon Clinical Multiaxial
Inventory – III (MCMI-III). Workshop presented at the Office of the Los Angeles
Public Defender.
25. Kalechstein, A., Ryan, E., van Gorp, W. G., Newton, T. F., & Duran, S. (2000).
Performance on neurocognitive tests predicts vocational functioning: A metaanalytic review. (Presented at the 108th Annual Meeting of the American
Psychological Association).
26. Kalechstein, A., & Wood, S. (2000). Invited Address: Competency Assessments in
Geriatric Clients. Workshop presented at Centinela Hospital, Los Angeles,
California.
27. Kalechstein, A., & Wood, S. (2000). Invited Address: Competency to Consent to
Medical Treatment: A Neuropsychological Approach. Workshop presented at
Centinela Hospital.
28. Kalechstein, A. (2001). Invited Address: Applications of Neuropsychological
Assessment in a Forensic Setting. Presented at Scripps College in Claremont, CA.
29. Newton, T., A., Kalechstein, A., Uslaner, J. M., Tervo, K. E., & Ling, W. (2001).
Risperidone reduces the euphorigenic effects of experimentally administered
cocaine. Presented at the 53rd Annual Meeting of the College on Problems of Drug
Dependence.

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 17 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 16

PRESENTATIONS AND PROFESSIONAL MEETINGS (cont.):
30. Newton, T. F., Kalechstein, A. D., & Tervo, K. E., & Ling, W. (2001). Irritability
following abstinence from cocaine predicts euphoric effects of cocaine
administration. Presented at the 53rd Annual Meeting of the College on Problems of
Drug Dependence.
31. Newton, T., A., Kalechstein, A., Uslaner, J. M., & Ling, W. (2001). Cocaine induced
“Liking” and “Wanting” are dissociable constructs: A test of incentive salience theory
in humans. Presented at the 53rd Annual Meeting of the College on Problems of Drug
Dependence.
32. Newton, T. F., Kalechstein, A. D., Hooper, K. B., & Ling, W. (2001). TheD2/5-HT2A
antagonist risperidone blunts cocaine-induced craving for cocaine. Presented at the
53rd Annual Meeting of the College on Problems of Drug Dependence.
33. Kalechstein, A.D., Newton, T. F., & Leavengood, A.H. (2001). Apathy syndrome in
cocaine dependence. Presented at the 53rd Annual Meeting of the College on
Problems of Drug Dependence.
34. Kalechstein, A. D., Newton, T. F., van Gorp, W. G., & Rubenstein, N. (2001). A metaanalytic review of the neurocognitive impairment associated with cocaine
dependence. Presented at the 53rd Annual Meeting of the College on Problems of
Drug Dependence.
35. Newton, T. F., Dertina, D., Kalechstein, A. D., VanSluis, N., Hooper, K. B., & Ling,
W. (2001). Intensity of Recent Cocaine Use Predicts Cocaine Induced Craving for
Cocaine. Presented at the 80th Annual Meeting of the Society for Neuroscience.
36. Stote, D. L., Newton, T. F., Kalechstein, A. D., and Roll, J. M. (2002). Is Priming by
Cocaine Context-Dependent? Presented at the 54th Annual Meeting of the College
on Problems of Drug Dependence.
37. Duran, S. D., Callahan, E., Newton, T. F.,Kalechstein, A. D., Twitchell, G., Davis, M.,
Steinberger, D.,
& Monroy, F.
(2002). Characterizing Withdrawal for
Methamphetamine Dependence Using Two Self-report Measures: Preliminary
Analysis. Presented at the 54th Annual Meeting of the College on Problems of Drug
Dependence.
38. Newton, T. F., Cook, I. A., Kalechstein, A. D., Duran, S. D., Monroy, F., Ling, W., &
Leuchter, A. F. (2002). Quantitative EEG Abnormalities in Recently Abstinent
Methamphetamine Dependent Individuals. Presented at the 54th Annual Meeting of
the College on Problems of Drug Dependence.
39. Twitchell, G.R., Davis, M. R., Williams, E. M., Kalechstein, A. D., & Newton, T. F.
(2002). Mood impairment in MDMA users: A meta-analytic review. Presented at
the 54th Annual Meeting of the College on Problems of Drug Dependence.

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 18 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 17

PRESENTATIONS AND PROFESSIONAL MEETINGS (cont.):
40. Kalechstein, A. D., & Rosenberg, J. E. (2002). Invited Address: Toward a Better
Understanding of the IME Process from the Perspective of the Examiner. Presented
at the 93rd Meeting of the International Claim Association, Santee Beach, Florida.
41. Kalechstein, A. D., Newton, T. F., Nestor, L., Cook, I. A., Leuchter, A. F. (2003).
Quantitative EEG Abnormalities are Associated with Memory Impairment in
Methamphetamine Dependence: Preliminary Findings. Presented at the 55 th
Annual Meeting of the College on Problems of Drug Dependence.
42. Kalechstein, A. D. (2003).
Invited Address: Identifying the Benefits of
Neuropsychological Assessment (Part 1). Presented at monthly rounds of Telecare
Corporation, Long Beach, California.
43. Kalechstein, A. D. (2003).
Invited Address: Identifying the Benefits of
Neuropsychological Assessment (Part 2). Presented at monthly rounds of Telecare
Corporation, Long Beach, California.
44. Kalechstein, A. D. (2003). Invited Address: Neuropsychological Assessment of
Psychiatric Disorders. Presented at weekly training for psychiatry residents at
Cedars-Sinai Hospital.
45. Kalechstein, A. D. (2003).
Invited Address: Identifying the Benefits of
Neuropsychological Assessment for Estate Planning Purpose. Presented at monthly
meeting for the San Gabriel Valley Fiduciary Group.
46. Abernathy, M. A., & Kalechstein, A. D. (2004). Psychotropic drugs: What they are
and when we need dementia authority. Presented at the annual meeting of the
Professional Fiduciary Association of California.
47. Kalechstein, A. D., Newton, T. F., De La Garza, R., & Mahoney, J. (2004). A Metaanalytic Review of the Association between Neuropsychological Functioning and
Recreational MDMA Use. Presented at the 75th Annual Meeting of the Society for
Neuroscience.
48. Cutting, D., Newton, T. F., Kalechstein, A. D., De La Garza, R., & Ling, W. (2004).
Apathy Predicts Cocaine-Induced Craving. Presented at the 75th Annual Meeting of
the Society for Neuroscience.
49. Kalechstein, A. D. (2005). Invited Address: Neurocognitive impairment as a core
symptom of addiction: Implications for treatment. Presented at weekly meeting of
the UCLA Addiction Clinic.
50. Kalechstein, A. D., Newton, T. F., & De La Garza, R., II. (2005). Acute
methamphetamine exposure worsens neurocognitive functioning. Presented at the
57th Annual Meeting of the College on Problems of Drug Dependence.

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 19 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 18

PRESENTATIONS AND PROFESSIONAL MEETINGS (cont.):
51.

Newton, T. F., Kalechstein, A. D., De La Garza, R., II, Cutting, D. J., & Ling, W.
(2005). Acute methamphetamine exposure worsens neurocognitive functioning.
Presented at the 57th Annual Meeting of the College on Problems of Drug
Dependence.

52. Mahoney, J. J., III, Kalechstein, A. D., De La Garza, R., II, & Newton, T. F. (2005).
A meta-analytic review of cocaine-induced craving. (Presented at the 57th Annual
Meeting of the College on Problems of Drug Dependence).
53. Fong, T., Newton, T. F., Roache, J. D., Kalechstein, A. D., De La Garza, R., II,
Wallace, C., Dawes, M., Bloch, D., Holmes, T., Elkashef, A. & Ling, W. (2005). The
subjective effects of intravenous methamphetamine during treatment with
bupropion. (Presented at the 57th Annual Meeting of the College on Problems of
Drug Dependence).
54. De La Garza, R., Kalechstein, A. D., II, Nestor, L., & Newton, T. F. (2005). A
dissociation of the subjective and cardiovascular effects produced by cocaine or
methamphetamine in stimulant-addicted patients. Presented at the 57th Annual
Meeting of the College on Problems of Drug Dependence.
55. Kalechstein, A. (2005). Invited Address: Forensic neuropsychology: A case
presentation. Presented at Scripps College in Claremont, CA.
56. Kalechstein, A. D., De La Garza, R., II, & Newton, T. F. (2006). Effects of Bupropion
SR on neurocognition in volunteers with methamphetamine. Presented at the 58 th
Annual Meeting of the College on Problems of Drug Dependence.
57. Newton, T. F., De La Garza, R., II, & Kalechstein, A. D. (2006). Methamphetamine–
or cocaine–induced craving: Cause or consequence of frequent drug use? Presented
at the 58th Annual Meeting of the College on Problems of Drug Dependence.
58. Jackson, B. J., Kalechstein, A. D., De La Garza, R., II, Harrison, L., Franco, Z., &
Newton, T. F. (2006). An evaluation of the effects of rivastigmine on neurocognition
in methamphetamine – dependent volunteers. Presented at the 58th Annual Meeting
of the College on Problems of Drug Dependence.
59. Kalechstein, A. D. (2006). Invited Address: Me and my R21: Some suggestions for
future grantsmen. Presented at the David Geffen School of Medicine, Semel
Institute for Neuroscience and Human Behavior, Psychiatry Fellowship.
60. Kalechstein, A. D. (2006). Invited Address: Are Methamphetamine–Associated
Neurocognitive Impairments Reversible? Presented at the Seminar for Addiction
Psychiatry at the David Geffen School of Medicine, Semel Institute for Neuroscience
and Human Behavior, Psychiatry Fellowship.
61. Kalechstein, A. D. (2006). Invited Address: The Benefits of Screening for Memory
Deficits. Presented at Senior Concerns, Thousand Oaks, CA, on National Memory
Screening Day.

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 20 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 19

PRESENTATIONS AND PROFESSIONAL MEETINGS (cont.):
62. Kalechstein, A. D. (2006). Invited Address: Neurocognition impairment and
pathological gambling: Integration of assessment protocols into epidemiological
research designs. Presented at Conference for Advancing Prevalence Studies on
Gambling Problems: International and Interdisciplinary Experiences with Theory,
Measurement, Design and Analysis.
63. Kalechstein, A. D. (2006). Invited Address: A day in the life of a neuropsychologist.
Presented at the Fiat Lux Seminar for UCLA freshmen at the David Geffen School of
Medicine, Semel Institute for Neuroscience and Human Behavior, Psychiatry
Fellowship.
64. Kalechstein, A. D., and J. Monterosso (2007). Invited Address: The importance
cognitive in relapse to methamphetamine. Presented at the weekly meeting for the
P20 Center for translational research at the David Geffen School of Medicine, Semel
Institute for Neuroscience and Human Behavior.
65. Kalechstein, A. D., & Jentsch, J. D. (2007). Symposium Moderators. Stimulant–
Associated Cognitive Abnormalities: Mechanisms and Impact on Reward-Related
Behavior and Addiction. Presented at the 59th Annual Meeting of the College on
Problems of Drug Dependence.
66. Kalechstein, A. D., De La Garza, R., II, Newton, T. F. (2007). Does pretreatment
with modafinil reverse methamphetamine – associated neurocognitive impairment?
Presented at the 59th Annual Meeting of the College on Problems of Drug
Dependence.
67. Kenny, C., Evans, S. E., De La Garza, R., II, Gunnia, G. G., Kalechstein, A. D., and
Newton, T. F. (2007). Self-perceived explanations for drug use and relapse among
methamphetamine-addicted volunteers. Presented at the 59th Annual Meeting of
the College on Problems of Drug Dependence.
68. Costello, M. A., De La Garza, R., II, Hurley, C. C., Fintzy, R. F., Kalechstein, A. D.,
and Newton, T. F. (2007). Unrestricted access to methamphetamine in the past is
associated with increased use of methamphetamine in the present. Presented at the
59th Annual Meeting of the College on Problems of Drug Dependence.
69. Mahoney, J. J., De La Garza, R., II, Yurovsky, B. C., Dillon, D. D., Kalechstein, A. D.,
and Newton, T. F. (2007). An analysis of the prevalence and persistence of psychotic
behaviors in cocaine- vs. methamphetamine–dependent participants. Presented at
the 59th Annual Meeting of the College on Problems of Drug Dependence.
70. Kalechstein, A. D. (2007). Invited Address: "Impaired Cognition as a Legal Defense
for Heinous Crimes - My Brain Made Me Do It!" Presented at Dinner with the Doctor
seminar for UCLA students.

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 21 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 20

PRESENTATIONS AND PROFESSIONAL MEETINGS (cont.):
71.

Jackson, B. J., Culbertson, C., Kalechstein, A. D., De La Garza, R., II, and Newton,
T. F. (2008). Acute modafinil administration does not improve cognitive function
in abstinent methamphetamine dependent individuals. Presented at the 59th Annual
Meeting of the College on Problems of Drug Dependence.

72. Kalechstein, A. D. (2008). Applications of neuroscience for the purpose of
explaining the behavior of pathological gamblers. Presented at the 25 th meeting of
the National Conference on Problem Gambling, Long Beach, California.
73. Kalechstein, A. D. (2008). Invited address: How neuropsychological assessment can
make your life easier. Presented at the weekly rounds for Country Villa staff meeting,
Pasadena, California.
74. Kalechstein, A. D. (2008). Invited address: Some commonly occurring problems
that affect brain functioning and capacity to drive safely. Presented at the
Department of Transportation, State of California.
75. Dean, A. C., London, E. D., Sugar, C.A., Kitchen, C. M., Swanson, A. N., Heinzerling,
K. G., Kalechstein, A. D., & Shoptaw, S. (2009). Predicting adherence to treatment
for methamphetamine dependence from neuropsychological and drug use variables.
Presented at the 61st Annual Meeting of the College on Problems of Drug
Dependence.
76. Tzotoris, D. Mahoney, J. J., Kalechstein, A. D., Newton, T. F., and De La Garza, R.,
II. (2010). Impulsivity + craving = drug use?. Presented at the 62nd Annual Meeting
of the College on Problems of Drug Dependence.
77. Haile, C. H., De La Garza, R., II, D. Mahoney, J. J., Kalechstein, A. D., and Newton,
T. F. (2010). Theories of addiction: Cocaine users’ explanation for continuing drug
use and relapse. Presented at the 62nd Annual Meeting of the College on Problems
of Drug Dependence.
78. Mahoney, J. J., Hawkins, D., De La Garza, R., II., Kalechstein, A. D., and Newton,
(2010). The relationship between gender and psychotic symptoms in cocaine—and
methamphetamine—dependent volunteers. Presented at the 62nd Annual Meeting
of the College on Problems of Drug Dependence.
79. Tziotoris, D., Mahoney, J. J., III, Kalechstein, A. D., Newton, T. F., & De La Garza,
R., II. (2010). Impulsivity + Craving = Drug Use. Presented at the 1 st Annual
Michael E. DeBakey VA Medical center Mental Health Research Conference.
80. Haile, C. H., De La Garza, R., II, D. Mahoney, J. J., Kalechstein, A. D., and Newton,
T. F. (2010). Theories of addiction: Cocaine users’ explanation for continuing drug
use and relapse. Presented at the 1st Annual Michael E. DeBakey VA Medical center
Mental Health Research Conference.

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 22 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 21

PRESENTATIONS AND PROFESSIONAL MEETINGS (cont.):
81. Yoon, J., Kalechstein, A. D., Croft, D. E., Ross, E. L., LaBounty, K. R., Mahoney, J.
J., III, Newton, T. F., De La Garza, R., II. (2011). Effects of D-cycloserine on
neurocognition among cocaine-dependent volunteers being treated for cigarette
smoking. Paper presented at the annual meeting of the Society for Research on
Nicotine and Tobacco, Toronto CANADA.
82. Mahoney, J.J., III, Kalechstein, A.D., Newton, T.F., Bennett, R., Arnoudse, N., Dao,
T.K., De La Garza, R., II. (2012). The Acetylcholinesterase Inhibitor, Rivastigmine,
but not Huperzine A, Improves Verbal Learning/Episodic Memory and Working
Memory in Cocaine-dependent Volunteers. Paper presented at the annual meeting
of American College of Neuropsychopharmacology (ACNP), Hollywood, FL.
83. Mahoney, J.J., III, Kalechstein, A.D., Newton, T.F., Yoon, J. H., Bennett, R.,
Arnoudse, N., Meyer, R., De La Garza, R., II. (2013). The Acetylcholinesterase
Inhibitor, Rivastigmine, but not Huperzine A, Improves Verbal Learning/Episodic
Memory and Working Memory in Cocaine-dependent Volunteers. Paper to be
presented at the annual meeting of Society for Research on Nicotine and Tobacco
(SRNT).
84. Mahoney, III, J.J., Kalechstein, A.D., Newton, T.F., Yoon, J.H., Bennett, R.S.,
Arnoudse, N., Meyer, S., De La Garza, II, R. (2013) Cigarette smoking does not affect
neurocognition in cocaine- or methamphetamine-dependent individuals. Society for
Research on Nicotine and Tobacco, Boston, MA.
85. Mahoney, III, J.J., Kalechstein, A.D., Verrico, C.D., Iqbal, T., Newton, T.F., De La
Garza, II, R. (2013). The Impact of Cocaine Use Patterns, Demographic and Mood
Variables, and Addiction Severity on Neurocognitive Functioning in Individuals
with Cocaine Use Disorders. Abstract to be presented December 8-12, 2013 at the
52nd annual American
College
of Neuropsychopharmacology meeting
in
Hollywood, FL.
86. Mahoney, III, J.J., Kalechstein, A.D., Newton, T.F., Meyer, S., Bennett, R., Chang,
L.,De La Garza, II, R. (2013). State versus Trait: Evaluating the stability of
neurocognitive functioning over time in cocaine-dependent participants. (2013,
June). College on Problems of Drug Dependence, San Diego, CA.
87. Kalechstein, A.D., Mahoney, III, J.J., Verrico, C.D., Iqbal, T., De La Garza, II, R.
(2014). Varenicline improves information processing speed and verbal memory in
methamphetamine (METH)-dependent participants. Poster to be presented at the
annual meeting of the College on Problems of Drug Dependence, San Juan, Puerto
Rico, June, 2014.
88. Mahoney, III, J.J., Kalechstein, A.D., Bajo, S., Reno, A., De Marco, A., Broshek, D.,
Newton, T.F., De La Garza, II, R. (2015). The Impact of Premorbid IQ on Cognitive
Functioning in Individuals with a Cocaine Use Disorder. International
Neuropsychological Society, Denver, CO.

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 23 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 22

PRESENTATIONS AND PROFESSIONAL MEETINGS (cont.):
89. Kalechstein, A. D. (2016). Invited address: Fundamental of neuropsychological
assessment. Presented at Daniels, Fine, Israel, Schobuch, & Lebovits.
90. Kalechstein, A. D. (2016). Invited address: Fundamental of neuropsychological
assessment. Presented at Veatch Carlson.
91. Mahoney, III, J.J., Kalechstein, A.D., Salas, R., Thompson-Lake, D., Bajo, S.D.,
Aduen, P., & De La Garza, II, R. (2016). Cognitive functioning in Cigarette-Deprived
Smokers.
Presented at the 44th Annual Meeting of the International
Neuropsychological Society, February, 2016.
92. Mahoney, III, J.J., Kalechstein, A.D., Bajo, S.D., Aduen, P., Newton, T.F., & De La
Garza, II, R. (2016). The impact of comorbid drug use and cocaine use patterns on
cognitive functioning in individuals with cocaine use disorders. Presented at the
44th Annual Meeting of the International Neuropsychological Society, February,
2016.
RESEARCH ACTIVITY:
Former investigator for the Human Neuropharmacology Unit at Baylor College of
Medicine: Prior research projects:
1. Effect of cocaine methamphetamine on striatal dopamine functioning, serotonergic
function, brain structure, and neuropsychological functioning.
2. Changes in neuropsychological functioning following administration
pharmaceutical interventions in stimulant dependent individuals.

of

3. Neuropsychological correlates of experimental manipulation of neurotransmitter
levels in normal controls and stimulant dependent individuals.
4. Neuropsychological correlates of treatment outcome in stimulant dependent
individuals.
Research assistant at Emory University Department of Neurology
Aided in the implementation of a longitudinal study (NIDRR grant: H133G30051)
examining the neurobehavioral sequelae of closed head injury in a sample of adults aged
50 and older.
Doctoral dissertation (completed 2/95)
Examined relationship between social learning theory constructs and various
achievement outcomes. Dissertation Chair: Stephen Nowicki, Jr., Ph.D.

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 24 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 23

CLINICAL TRAINING:
UCLA NEUROPSYCHIATRIC INSTITUTE

Los Angeles, CA

Postdoctoral Fellowship in Neuropsychology (9/95 to present): Training
objectives include advanced understanding of neuropsychological theory and application
within medical, legal, and community settings. Cases referred include traumatic brain
injury, cerebrovascular accidents, cortical and subcortical dementia, HIV-1 infection,
affective disorders, substance abuse, seizure disorders, psychosis, learning disabilities,
forensic issues, and Axis II disorders.
AIDS Project Los Angeles

Los Angeles, CA

Neuropsychology Program Coordinator (11/95 to present): Developed referral
network from groups within agency as well as other AIDS-service agencies within the
community, provided in-service presentations to various groups within APLA,
coordination and tracking of performance by neuropsychology team, liaison between
UCLA and APLA, evaluation of clients.
VA MEDICAL CENTER, WEST LOS ANGELES

Los Angeles, CA

Neuropsychology/Neurobehavior Rotation (9/94 to 3/94): Developed skills to
formulate testing protocols to answer particular referral questions, proficiency at patient
interviews and test administration, and the skills to integrate the interview and testing
data into a report with recommendations for the referral source. Cases commonly
referred to laboratory include cerebrovascular accidents, cortical and subcortical
dementia, AIDS-dementia complex, head injury, affective disorders, seizure disorders,
psychosis, dual diagnosis, and Axis II disorders.
VA MEDICAL CENTER, WEST LOS ANGELES

Los Angeles, CA

Forensic Psychology Rotation (3/95 to 9/95): Training focused on the integration
between legal and psychological issues, development of the skills to testify at criminal and
civil hearings, to conduct forensic interviews, to assess patient competency (PC 1370) and
insanity at the time of an offense (PC 1026) due to psychosis, substance abuse, dual
diagnosis, malingering, neurologic disorders, and Axis II disorders.
PATTON STATE HOSPITAL

Highland, CA

Forensic Psychology Rotation (3/95 to 9/95): Training focused on forensic issues
in criminal proceedings. Referral questions include patient competency (PC 1370) and
insanity at the time of an offense (PC 1026) due to psychosis, substance abuse, dual
diagnosis, neurologic disorders, and Axis II disorders.

Case 2:21-cv-00296-APG-BNW Document 61-2 Filed 02/06/24 Page 25 of 25
Curriculum vitae: Ari Kalechstein, Ph.D.
Date: 08/25/2022
Page: 24

CLINICAL TRAINING (cont.):
EMORY UNIVERSITY (GRADY HOSPITAL)

Atlanta, GA

Psychology Extern: (2/91-5/91): Administered and scored tests; prepared written
reports and provided test feedback to patients on the locked unit with severe psychiatric
disorders (Room 800-B); reports conceptualized using a psychodynamic framework.
EMORY UNIVERSITY PSYCHOLOGY CENTER

Atlanta, GA

Psychology Extern: (9/90 to 12/90; 5/91 to 5/94):
Assessment: Conducted child, adolescent, and adult testing and interviews;
Administered and scored tests; prepared written reports and provided test feedback to
clients. Reports were conceptualized within a neuropsychological framework and/or
problem oriented framework; Other types of testing experience include personality and
vocational testing: Referral questions included IQ and/or achievement assessment;
differential diagnosis of learning disabilities and emotional dysfunction; comprehensive
assessment of neuropsychological factors associated with learning disabilities.
EMORY UNIVERSITY PSYCHOLOGY CENTER

Atlanta, GA

Individual Psychotherapy: Provided weekly or twice-weekly sessions with short- and
long-term community clients; prepared initial evaluation summaries, progress notes, and
termination and transfer summaries. Presenting problems include affective disorders,
anxiety disorders, adjustment disorders, personality disorders, suicidal ideation, and
relationship difficulties. Supervision in Sullivanian interpersonal, psychodynamic,
cognitive-behavioral, and systems approaches.
TEACHING EXPERIENCE:
Co–instructor (Spring 2007): A Translational Approach to Investigating the
Neurobiological Basis of Drug Addiction. The proposed course will cover major topics in
drug addiction by emphasizing the use of animal models to understand human addiction,
and to disclose how findings derived from human studies can be used to expand the
development of animal models.
Seminar Instructor (1/95): Conducted seminar to train advanced clinical
psychology students from UCLA on the administration of the Rorschach Inkblot Test.
Graduate Teaching Assistant: Introductory Statistics (8/91 -12/91): Prepared
lectures; reviewed coursework with students in class and on an individual basis; assisted
in preparation and scoring of exams.